Literature DB >> 2303033

Genetic ablation of a mouse gene expressed specifically in brain.

D M Kingsley1, E M Rinchik, L B Russell, H P Ottiger, J G Sutcliffe, N G Copeland, N A Jenkins.   

Abstract

The 1B1075 gene was initially identified from a cDNA clone of a rat brain messenger RNA expressed in particular subsets of CNS neurons and pituitary cells. Although the protein encoded by this gene is of unknown function, its sequence suggests that it may be related to secretogranin proteins, which are found in association with secretory granules in a variety of peptidergic endocrine and neuronal cells. Here we show that the mouse 1B1075 gene is located between the dilute (d) and short ear (se) genes on chromosome 9. Many different deletion mutations have previously been isolated in the genetic region that includes these genes. By producing mice carrying two deletions that overlap at the 1B1075 locus, the gene for this brain-specific message can be completely eliminated from otherwise viable animals. The animals missing the 1B1075 gene provide an important new tool for determining the function of this gene in the brain. In addition, these results provide a new molecular entry point for detailed characterization of other genes in the d-se region.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2303033      PMCID: PMC551679          DOI: 10.1002/j.1460-2075.1990.tb08123.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  21 in total

1.  Allelic variation within the Emv-15 locus defines genomic sequences closely linked to the agouti locus on mouse chromosome 2.

Authors:  L D Siracusa; L B Russell; N A Jenkins; N G Copeland
Journal:  Genetics       Date:  1987-09       Impact factor: 4.562

2.  X-ray-induced mutations in mice.

Authors:  W L RUSSELL
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1951

3.  Molecular genetic analysis of the dilute-short ear (d-se) region of the mouse.

Authors:  E M Rinchik; L B Russell; N G Copeland; N A Jenkins
Journal:  Genetics       Date:  1986-02       Impact factor: 4.562

4.  Functional and structural analyses of mouse genomic regions screened by the morphological specific-locus test.

Authors:  L B Russell
Journal:  Mutat Res       Date:  1989-05       Impact factor: 2.433

5.  "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

6.  One-step gene disruption in yeast.

Authors:  R J Rothstein
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

7.  The Drosophila Abelson proto-oncogene homolog: identification of mutant alleles that have pleiotropic effects late in development.

Authors:  M J Henkemeyer; F B Gertler; W Goodman; F M Hoffmann
Journal:  Cell       Date:  1987-12-04       Impact factor: 41.582

8.  A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice.

Authors:  M R Kuehn; A Bradley; E J Robertson; M J Evans
Journal:  Nature       Date:  1987 Mar 19-25       Impact factor: 49.962

9.  Lethal disruption of the yeast actin gene by integrative DNA transformation.

Authors:  D Shortle; J E Haber; D Botstein
Journal:  Science       Date:  1982-07-23       Impact factor: 47.728

10.  Multiple transcripts of the mouse tyrosinase gene are generated by alternative splicing.

Authors:  S Ruppert; G Müller; B Kwon; G Schütz
Journal:  EMBO J       Date:  1988-09       Impact factor: 11.598

View more
  24 in total

Review 1.  Mouse chromosome 9.

Authors:  D M Kingsley
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

Review 2.  Mouse chromosome 9.

Authors:  D M Kingsley
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

3.  Identification of a chromogranin A domain that mediates binding to secretogranin III and targeting to secretory granules in pituitary cells and pancreatic beta-cells.

Authors:  Masahiro Hosaka; Tsuyoshi Watanabe; Yuko Sakai; Yasuo Uchiyama; Toshiyuki Takeuchi
Journal:  Mol Biol Cell       Date:  2002-10       Impact factor: 4.138

Review 4.  Ligandomics: a paradigm shift in biological drug discovery.

Authors:  Wei Li; Iok-Hou Pang; Mario Thiego F Pacheco; Hong Tian
Journal:  Drug Discov Today       Date:  2018-01-08       Impact factor: 7.851

5.  Anti-secretogranin III therapy of oxygen-induced retinopathy with optimal safety.

Authors:  Fen Tang; Michelle E LeBlanc; Weiwen Wang; Dan Liang; Ping Chen; Tsung-Han Chou; Hong Tian; Wei Li
Journal:  Angiogenesis       Date:  2019-01-14       Impact factor: 9.596

6.  Novel peptides from adrenomedullary chromaffin vesicles.

Authors:  J Sigafoos; W G Chestnut; B M Merrill; L C Taylor; E J Diliberto; O H Viveros
Journal:  J Anat       Date:  1993-10       Impact factor: 2.610

Review 7.  Secretogranin III: a diabetic retinopathy-selective angiogenic factor.

Authors:  Wei Li; Keith A Webster; Michelle E LeBlanc; Hong Tian
Journal:  Cell Mol Life Sci       Date:  2017-08-30       Impact factor: 9.261

8.  Molecular genetics of the brown (b)-locus region of mouse chromosome 4. II. Complementation analyses of lethal brown deletions.

Authors:  E M Rinchik
Journal:  Genetics       Date:  1994-07       Impact factor: 4.562

9.  129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal.

Authors:  J C Manson; A R Clarke; M L Hooper; L Aitchison; I McConnell; J Hope
Journal:  Mol Neurobiol       Date:  1994 Apr-Jun       Impact factor: 5.590

10.  A large form of secretogranin III functions as a sorting receptor for chromogranin A aggregates in PC12 cells.

Authors:  Lu Han; Masayuki Suda; Keisuke Tsuzuki; Rong Wang; Yoshihide Ohe; Hirokazu Hirai; Tsuyoshi Watanabe; Toshiyuki Takeuchi; Masahiro Hosaka
Journal:  Mol Endocrinol       Date:  2008-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.